BMEDiShares Health Innovation Active ETF
Grow my money#2145 of 2944 for Grow my money
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
BlackRock · Since 2020 (5 years)
Annual Cost
0.55%
#2614 out of 5,332 ETFs
Fund Size
$10M
#4506 out of 5,332 ETFs
Dividend Yield
0.00%
Track Record
5 years
#2245 out of 5,332 ETFs
Performance
1 Year
+14.7%
3 Years
+5.2%
5 Years
-1.6%
What's inside
Asset class
Region
Focus
Biotech & Genomics
Asset allocation
Stocks
94.7%
Cash
5.3%
Sector breakdown
Healthcare
100.0%
Top holdings
Johnson & JohnsonJNJ8.0%
Merck & Co IncMRK5.6%
Gilead Sciences IncGILD5.5%
BlackRock Cash Funds Treasury SL AgencyXTSLA5.2%
Amgen IncAMGN4.5%
Edwards Lifesciences CorpEW4.3%
Biogen IncBIIB3.4%
Guardant Health IncGH3.0%
WuXi Biologics (Cayman) Inc2269.HK3.0%
Mettler-Toledo International IncMTD2.9%
Risk profile
Volatility (1Y)
15.4%
Moderate
Max drawdown
-36.4%
Worst peak-to-trough loss
Sharpe (3Y)
0.17
Below average
Sortino (3Y)
0.24
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05